All News

Your weekly roundup of the latest news from Drug Topics®.

CDC survey finds Interventions are needed to facilitate the implementation of updated pneumococcal vaccine recommendations, HHS proposes a new rule the seeks to prohibit discrimination based on disabilities, and a new report says there is a need for improved access to pediatric subspecialty care.

Updated COVID-19 booster shots may be approved by Friday, health insurance costs continue to increase, and republicans with 3 house committees plan to introduce PBM reform bill.

The CDC issues an alert for increased RSV activity, a survey finds men's habits don't stack up to their perceptions on their health, and the WHO announces an air pollution training course for health care workers.

The 2023 Healthcare Advocate Summit is September 5 to 9 in New Orleans, Louisiana.

Your weekly roundup of the latest news from Drug Topics®.

The FDA plans to finalize its ban on menthol tobacco products in the coming months, and the Department of Health and Human Services proposes comprehensive staffing requirements for nursing homes.

Your monthly roundup of the top news from Drug Topics®.

The FDA issues warning letters to 3 infant formula manufacturers for violations, and officials with the Department of Health and Human Services recommend reclassifying marijuana as a schedule III drug.

Sometimes, breaches in information are the result of a simple mistake. How can those be avoided?

Narcan is set to be available at several drugstore and grocery chains in the US early next week, and Walmart announced a new "Testing and Treatment" program at its pharmacies in 12 states.

CMS announces the first 10 drugs selected for price negotiation under Medicare Part D, and a new study finds prescriptions for fruits and vegetables can improve health outcomes for people at increased risk of cardiovascular disease.

Your weekly roundup of the latest news from Drug Topics®.

The new deadline to be in compliance with the requirements will be November 27, 2024.

Sandoz's injection treatment natalizumab-sztn (Tyruko) is the first biosimilar approved by the health agency for the treatment of multiple sclerosis.

HHS awards money for mental health awareness training, UnitedHealthcare pays $80,000 over potential HIPPA violation, and the FDA issues a recall for sub-acute care ventilators.

CVS Health joins the biosimilar market, the FDA issues warning about contaminated eye drops, and the CDC says not to kiss your pet turtle because of salmonella.

One in 5 women report mistreatment during maternity care, employers see rise in mental health challenges, and Microsoft teams up with Epic to increase the use of AI in healthcare.

Poll finds Americans still struggle with health misinformation, CMS release new guidance on out-of-pocket Prescription Drug Cost Program, and experts call for continued masking in health care settings.

NIH establishes research centers for maternal health, FDA grants priority review for IgA nephropathy treatment, and the CDC begins tracking a new COVID-19 variant.

Appeals court puts restrictions on access to mifepristone, Blue Shield of California drops CVS Health, and Americans think opioids and obesity are the 2 biggest threats to public health.

National organizations call for Improvements to youth mental health care, Wednesday marks 1 year since passing of Inflation Reduction Act, and a new study finds link between fracking and lymphoma.

In the pharmacy field, customers are not often knowledgeable about the specifics of the products they are purchasing. How can your pharmacy make sure customers get exactly what they need?

Philips recall declared class I by the FDA, HHS launches civil rights investigation into Tennessee medical center, and experts warn about chemicals released into air and water during Maui wildfires.

The act is currently set to go into effect in just over three months.

Your weekly roundup of the latest news from Drug Topics®.

HHS awards money to fight the nursing shortage, the FDA approves Johnson & Johnson's talquetamab-tgvs (TALVEY), and the CDC says suicides reached an all-time high in 2022.

WHO upgrades EG.5 to "variant of interest," Amazon-owned One Medical expands across US, and health officials urge vaccination before the coming fall season.

COVID-19 hospitalizations tick up, Wegovy shows cardiovascular benefit, and health care organizations team up to fight overdose deaths in New Jersey.

What's on the agenda for FTP in the month to come?